Amy Chang - Procter Gamble Independent Director

PG -  USA Stock  

USD 141.70  3.34  2.30%

  Director
Ms. Amy L. Chang is an Independent Director of the company. Ms. Chang is Senior Vice President of the Collaboration Technology Group at Cisco Systems, Inc. . She is the founder and former Chief Executive Officer of Accompany, Inc., a position she held from 2013 to 2018. She previously held positions of increasing responsibility at Google, Inc. from 2005 to 2012, most recently serving as Global Head of Product, Google Ads Measurement and Reporting. Prior to joining Google, she held product management and strategy positions at eBay, Inc. and served as a consultant with McKinsey Company, specializing in semiconductors, software, and services. Ms. Chang was a Director of Cisco Systems, Inc. from 2016 to 2018, a Director of Informatica from 2012 to 2015, a Director of Splunk, Inc. from 2015 to 2017, and a member of Target Corporationrationrations Digital Advisory Council from 2013 to 2016
Age: 44  Director Since 2017      
513 983 1100  https://www.pginvestor.com
Chang’s mix of extensive Digital, Technology, and Innovation and Marketing experience, including as founder and CEO of Accompany and as Global Head of Product, Google Ads Measurement and Reporting, uniquely situates her to provide important insights about digital industry trends, evolving marketing practices and data analytics to the Board. Additionally, as the founder of a digital startup company, Ms. Chang’s Leadership, Strategy, and Risk Management experience in a fastpaced environment gives her critical perspective on understanding consumers and driving innovation.

Amy Chang Latest Insider Activity

Tracking and analyzing the buying and selling activities of Amy Chang against Procter Gamble stock is an integral part of due diligence when investing in Procter Gamble. Amy Chang insider activity provides valuable insight into whether Procter Gamble is net buyers or sellers over its current business cycle. Note, Procter Gamble insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procter Gamble'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Procter Gamble Management Efficiency

Procter Gamble has Return on Asset (ROA) of 9.51 % which means that for every $100 of asset, it generated profit of $9.51. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 31.09 %, which means that it produced $31.09 on every 100 dollars invested by current stockholders. Procter Gamble management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company reports 35.65 B of total liabilities with total debt to equity ratio (D/E) of 0.79, which is normal for its line of buisiness. Procter Gamble has a current ratio of 0.66, implying that it has not enough working capital to pay out debt commitments in time. Debt can assist Procter Gamble until it has trouble settling it off, either with new capital or with free cash flow. So, Procter Gamble's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procter Gamble sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procter to invest in growth at high rates of return. When we think about Procter Gamble's use of debt, we should always consider it together with cash and equity.
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine Procter Gamble value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Similar Executives

Showing few of many executives

DIRECTOR Since

Bridget BermanNewell Brands
N/A
Werner GeisslerPhilip Morris International
2015
Nevin AndersenNu Skin Enterprises
2008
John LechleiterNike Inc
2009
Christopher OLearyNewell Brands
2014
Adam HanftScotts Miracle-Gro
2016
Sergio MarchionnePhilip Morris International
2008
Craig HargreavesScotts Miracle-Gro
2018
Scott PondNu Skin Enterprises
2018
Brett IcahnNewell Brands
2018
Michael GeorgeRalph Lauren Corp
2018
Kevin ConroyNewell Brands
2011
Alan GrafNike Inc
2014
Harold BrownPhilip Morris International
2008
Robert PoletPhilip Morris International
2011
John AlchinRalph Lauren Corp
2007
Xinzhe LiPhilip Morris International
2010
Jose PerezLizaurNewell Brands
2012
Thomas PisanoNu Skin Enterprises
2008
Katherine LittlefieldScotts Miracle-Gro
2000
Cynthia MontgomeryNewell Brands
1995
The Procter Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. Procter Gamble operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 101000 people. Procter Gamble (PG) is traded on New York Stock Exchange in USA and employs 101,000 people.

Procter Gamble Leadership Team

Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, Chief Research, Development and Innovation Officer
Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures
Kenneth Chenault, Independent Director
Debra Lee, Independent Director
Mindy Sherwood, President Global Walmart
Amy Chang, Independent Director
Nelson Peltz, Independent Director
Martin Riant, Group Pres and Advisor to the CEO
Hatsunori Kiriyama, President - Asia
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations
Kirti Singh, Chief Analytics and Insights Officer
Tarek Farahat, President - Latin America
Francis Blake, Independent Director
Thomas Finn, President - Personal Health Care
Mohamed Samir, President - India, Middle East and Africa (IMEA) Selling and Market Operations
Alexandra Keith, President - Global Hair Care and Beauty Sector
Susan DesmondHellmann, Independent Director
Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader
Fama Francisco, Chief Executive Officer - Baby and Feminine Care
Loic Tassel, President - Europe
Margaret Whitman, Independent Director
Walter McNerney, Lead Independent Director
Terry Lundgren, Independent Director
Shelly McNamara, Senior Vice President of Human Resources
Angela Braly, Independent Director
Giovanni Ciserani, Group President of Global Fabric and Home Care and Global Baby and Feminine Care
M Grabowski, Chief Human Resource Officer
Victor Aguilar, Chief Research, Development and Innovation Officer
Javier Polit, Chief Information Officer
B Allen, Independent Director
James McNerney, Lead Independent Director
Ernesto Zedillo, Independent Director
Steven Bishop, Group President - Global Feminine and Family Care
Scott Cook, Independent Director
Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China
Sundar Raman, President - Fabric Care, North America and P&G Professional, Global
Ernesto Leon, Independent Director
R Keith, President - Global Hair Care and Beauty Sector
Ma Francisco, Chief Executive Officer - Baby and Feminine Care
Yannis Skoufalos, Global Product Supply Officer
Linda ClementHolmes, CIO
Jennifer Davis, President - Feminine Care
John Chevalier, Director - Investor Relations
Juan Posada, President - Latin America Selling and Market Operations
Alan Lafley, Executive Chairman and Member of Proxy Committee
Jeffrey Schomburger, Global Sales Officer
Monica Turner, Senior Vice President - Sales, North America
Vittorio Cretella, Chief Information Officer
Christine McCarthy, Independent Director
Patricia Woertz, Independent Director
Shailesh Jejurikar, Chief Operating Officer, Chief Executive Officer - Fabric and Home Care
Philip Duncan, Chief Design Officer
Andre Schulten, Chief Financial Officer
Marc Pritchard, Global Brand Building Officer
Markus Strobel, President - Skin & Personal Care
David Taylor, Chairman of the Board, President, Chief Executive Officer
Mark Biegger, Global Human Resources Officer
Joseph Jimenez, Lead Independent Director
Matthew Price, President - Greater China Selling and Market Operations
Julio Nemeth, President - Global Business Services
Laura Becker, President - Global Business Services
Deborah Majoras, Chief Legal Officer, Secretary
Jon Moeller, Vice Chairman of the Board, President, Chief Executive Officer
Patrice Louvet, Group President - Global Beauty
Charles Pierce, Group President - Global Grooming
Gary Coombe, President - Europe Selling and Market Operations
Carolyn Tastad, Group President - North America Selling and Market Operations

Procter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Procter Gamble without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Currently Active Assets on Macroaxis

Please check Your Equity Center. Note that the Procter Gamble information on this page should be used as a complementary analysis to other Procter Gamble's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Procter Stock analysis

When running Procter Gamble price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Is Procter Gamble's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine Procter Gamble value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.